UnknownNot applicableNCT00103766

Alteplase for Treatment of Empyema and Complicated Parapneumonic Effusion

Studying Pleural empyema

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
O'Brien, Jeana D., MD, FACP, FCCP
Principal Investigator
Jeana D O'Brien, MD, FACP, FCCP
Scott and White Memorial Hospital and Scott, Sherwood and Brindley Foundation
Intervention
Alteplase(drug)
Enrollment
75 target
Eligibility
18 years · All sexes
Timeline
2004

Study locations (1)

Collaborators

Genentech, Inc. · Scott and White Hospital & Clinic · Scott, Sherwood and Brindley Foundation · Texas A&M University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00103766 on ClinicalTrials.gov

Other trials for Pleural empyema

Additional recruiting or active studies for the same condition.

See all trials for Pleural empyema →

← Back to all trials